Experimental drug shows early promise against inherited form of ALS, trial indicates

A clinical trial has found evidence that the experimental drug tofersen lowers levels of a disease-causing protein in people with an inherited form of amyotrophic lateral sclerosis, or ALS, caused by mutations in the gene SOD1.

[ad_2]

Source link

0 Reviews

Write a Review

Read Previous

[VIDÉO] Ganesh Chaturthi / Venkateshwara Pooja : le PM préside la première réunion de la Task Force

Read Next

Décès de l'acteur vétéran Jagdeep «Soorma Bhopali» de «Sholay»